Ossio Inc
$357.9K 248 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Genmab BV
Genmab BV reported $357,675.58 across General Payments, Research, and Ownership to 4 physicians and teaching hospitals across 77 transactions.
- $357.7K Above-median payer
- All-tracks total
- 77 Below-median volume
- Transactions
- 4 Below-median reach
- Recipients
- #854
- of 1,925 companies
Genmab BV reported $357,675.58 across all CMS Open Payments tracks (General + Research + Ownership) to 4 physicians and teaching hospitals in Program Year 2024 - ranking #854 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $51,500.00, averaging $89.4K per recipient.
How Genmab BV's $357.7K all-tracks total breaks down
Genmab BV's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
11/100
Total payments
F
13/100
Transaction volume
F
11/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer genmab-bv Genmab BV
$357.7K · #854/1,925 · 0.0% industry · PY2024
- TOT $357.7K
- RANK #854
- SHARE 0.0%
- TXN 77
- RCP 4
- CAT 1
- GEN $51.5K
- TOP1 56.3%
- PY 2024
Volume peers
Nearest volume peer: Ossio Inc ($357.9K)
Genmab BV sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Genmab BV
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Genmab BV, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Compensation for Services Other Than Consulting" leads the 1-category general-payment breakdown below at $51.5K (100.0% of General Payments, 4 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
Across 1 types of general payments, Genmab BV's largest category was "Compensation for Services Other Than Consulting" at $51.5K - 100.0% of General Payments.
How Genmab BV divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $51.5K | 4 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $51,500.00 (100.0%) of $51,500.00 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Genmab BV
The five named recipients with the highest reported General Payments from this company
- 1
Ut Md Anderson Cancer Center
$29,000.00 across 3 reported transactions
- 2
University Of Washington Med Ctr
$22,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Genmab BV ranks #854 of 1,925 by total payments (top 44% by spend) but is notably more concentrated than that alone would suggest -- #346 of 1,838 by HHI (top 19% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Dentsply Sirona Pty Limited : $34.5K total payments, HHI 5119
- FHC, Inc. : $19.6K total payments, HHI 5112
- GRT US Holding, Inc. : $32.4K total payments, HHI 5103
- Modulated Imaging, Inc. : $28.0K total payments, HHI 5102
- RxSight Inc : $11.1M total payments, HHI 5097
- Strategic Dentistry LLC : $1.7K total payments, HHI 5083
- Genmab BV (this company) : $51.5K total payments, HHI 5080
- Amnio Technology, LLC : $11.7K total payments, HHI 5078
- New Age Medical LLC : $137.0K total payments, HHI 5077
- Infinity BiologiX LLC : $52.4K total payments, HHI 5072
- Olympus Winter & Ibe GmbH : $34.4K total payments, HHI 5067
- Intellijoint Surgical Inc. : $32.2K total payments, HHI 5059
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Genmab BV's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Genmab BV.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Genmab BV.
Showing 6 of 1,924 companies with CMS-reported payment data.
SOMAVAC Medical Solutions, Inc.
$354.1K 17 recipients
Compare payment profiles
UCB GmbH
$354.0K 1 recipients
Compare payment profiles
Heidelberg Engineering, Inc.
$361.5K 68 recipients
Compare payment profiles
Biogennix, LLC
$352.9K 66 recipients
Compare payment profiles
Kuraray America Inc.
$352.3K 611 recipients
Compare payment profiles
Put this to use
Genmab BV ranks #854 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Genmab BV. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.